SBiS 2020 : A Decade of Building a Global Korean Vascular Network
쉐라톤 서울 팔래스 강남 호텔 다이너스티홀
08:30-08:50	Registration 사회: 박형섭 (서울의대)
08:50-08:55	Opening Address Ku Yong Jeong (Ewha Womans Univ.)
08:55-09:00	Course review Taeseung Lee (Seoul National Univ.)
Session 1. LIVE connection with USA (I)
09:00-10:30	Moderators: Taeseung Lee (Seoul National Univ.) Hyung Sub Park (Seoul National Univ.)
09:00-09:15	Recorded live case 1: Transcarotid Arterial Revascularization (TCAR) Jae S Cho (Case Western Reserve Univ., USA)
09:15-09:30	Recorded live case 2: In-Situ FEVAR for ruptured unstable TAAA Sukgu M Han (Univ. of Southern California, USA)
09:30-09:45	Vascular surgeon's role during the COVID-19 pandemic: experience in the heart of NY Daniel K. Han (Mount Sinai Univ., USA)
09:45-10:00	Perioperative thromboprophylaxis in COVID-19 patients Cheong Jun Lee (Northshore Univ., USA)
10:00-10:15	BMT vs CEA vs CAS in asymptomatic carotid disease patients Jae S Cho (Case Western Reserve Univ., USA)
10:15-10:30	Customized FEVAR/BEVAR vs PMEG
10:30-10:50	Coffee break
Session 2. LIVE connection with USA (II)
10:50-12:20	Moderators: Sangil Min (Seoul National Univ.)
10:50-11:05	Bridging covered stents during FEVAR/BEVAR: which is best and why?
11:05-11:20	Neoaortoiliac System (NAIS) Procedure for Infected Aortic Graft Treatment Jayer Chung (Baylor Univ., USA)
11:20-11:35	DCB/DES use in claudicants vs critical limb ischemia patients: should they differ? Cheong Jun Lee (Northshore Univ., USA)
11:35-11:50	Guideline-based role of surgery in PAD: Will the BASIL-2 and BEST-CLI trials be a game changer? Jayer Chung (Baylor Univ., USA)
11:50-12:20	Debate: The current status of the endovascular drive in thoracoabdominal aorta pathology
	1. Deviating from the endo track (back to open) Suk Won Song (Yonsei Univ.)
	2. Still in track with some minor bumps (endo favored) Sukgu M Han (Univ. of Southern California, USA)
Special Session. LUNCHEON (Sponsored by BD Bard)
12:30-13:30	Moderators: Jongwon Ha (Seoul National Univ.)
12:30-13:30	Recorded lecture: Optimize Venous Stenting Outcomes : 24 month Vernacular Trial Results & Lessons Learned from the Expert on Venous Stenting Paul Gagne (Norwalk Hospital)
Session 3. Deep venous intervention: In Depth
13:30-14:50	Moderators: In Mok Jung (Seoul National Univ.) Sang Woo Park (Konkuk Univ.)
13:30-13:40	Recorded live case 3: PMEG for TAAA
13:40-13:50	Limitations of the CAVENT, ATTRACT and CAVA trials: Is anticoagulation alone enough for acute DVT Young Sun Yoo (Chosun Univ.)
13:50-14:00	Advantages of pharmacomechanical thrombectomy for deep vein thrombosis Sang Woo Park (Konkuk Univ.)
14:00-14:10	Thrombotic vs nonthrombotic iliocaval obstruction: Management strategies for CVI intervention Hyung Sub Park (Seoul National Univ.)
14:10-14:20	Medical management after deep venous stenting Keun Myoung Park (IIncheon Vascular Surgery)
14:20-14:30	Can all chronically occluded IVC filters be removed? Tips and tricks Je Hwan Won (Ajou Univ.)
14:30-14:50	Panel discussion
14:50-15:10	Coffee break
Session 4. Drug-based technology in PAD: Issues and solutions
15:10-16:20	Moderators: Sang Joon Kim (Professor Emeritus, Seoul National Univ.) Hwan Jun Jae (Seoul National Univ.)
15:10-15:20	One year since the DCB issue: what's the current evidence Suh Min Kim (Chung-Ang Univ.)
15:20-15:30	Pharmacology and toxicity of Paclitaxel: what's the influence? Seung-Woon Rha (Korea Univ.)
15:30-15:40	Is the increase in patency of drug-based technology justifiable in terms of cost-effectiveness? Chang-Hwan Yoon (Seoul National Univ.)
15:40-15:50	Updates on drug-based technology for BTK intervention Jae Hwan Lee (Chungnam National Univ.)
15:50-16:00	Strategies to improve drug-delivery efficiency in the SFA: are we dealing aggressively enough with the calcium burden? Jang Yong Kim (Catholic Univ.)
16:00-16:20	Panel discussion
Session 5. The Aorta Essentials
16:20-18:00	Moderators: Yong-Pil Cho (Ulsan Univ.) Youngwook Kim (Sungkyunkwan Univ.)
16:20-16:30	Recorded live case 4: Late open conversion after EVAR
16:30-17:00	Debate: Lowering the diameter threshold of EVAR to less than 5.5 cm
	1. Yes, an overstreched spring never comes back Kwang Hun Lee (Yonsei Univ.)
	2. No, that is not evidence-based or cost-effective Sang Su Lee (Pusan National Univ.)
17:00-17:10	Updates in medical treatment of AAA: the same old guys or any new kids on the stage? Jin Mo Kang (Gachon Univ.)
17:10-17:20	Implications of the NICE guideline: should all elective AAAs be treated surgically?
17:20-17:30	Unveiling sac biology: Rapid sac growth phenomenon after EVAR compared to untreated natural AAA - What's the implication? Jin Hyun Joh (Kyung Hee Univ.)
17:30-17:40	Late ruptures of AAA after EVAR Seung Huh (Kyungpook National Univ.)
17:40-17:50	EVAR for ruptured AAA: ways to increase implementation. Sun Cheol Park (Catholic Univ.)
17:50-18:00	Panel discussion
18:00-00:00	Closing Remarks